Clinical Trials Browser

Phase 3 × Head and Neck Neoplasms × avelumab × Clear all

NCT02999087 2025-05-07

REACH

Phase 3 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms